MBX

MBX Biosciences, Inc. is a clinical-stage biopharmaceutical firm based in Carmel, Indiana, dedicated to the discovery and development of cutting-edge precision peptide therapies targeting endocrine and metabolic disorders. Utilizing its proprietary technology platform, MBX is vigorously advancing its innovative therapeutic candidates through extensive clinical trials. By concentrating on critical unmet medical needs in its therapeutic areas, the company is well-positioned to achieve substantial growth and make a significant impact within the biopharmaceutical industry.